New Partnership to Test Promising Therapies for CMT4B1

New Partnership to Test Promising Therapies for CMT4B1

298134

New Partnership to Test Promising Therapies for CMT4B1

The CMT Research Foundation has teamed up with AcuraStem and scientist Alessandra Bolino, PhD, to test potential new therapies for Charcot-Marie-Tooth disease type 4B1 (CMT4B1), a severe form of the disease with early onset. CMT4B1 is caused by mutations in the gene MTMR2, which is involved in the production of the myelin sheath — the protective layer of nerve fibers — by breaking down a fatty molecule called PI(3,5)P2. Mutations in MTMR2 lead to accumulation of this…

You must be logged in to read/download the full post.